2025-03-29 20:48:03
Latest Post
Bharat's largest solar cell manufacturing Gigafactory inaugurated by Waaree Energies in Chikhli, Gujarat
Purple Finance Limited sells portion of its portfolio to Ambit Finvest Pvt Ltd
Kumbhat Financial Services Limited allots 5.78 lakh shares to promoter Sanjay Kumbhat 
Solarium Green Energy Ltd receives order from BSF Jammu
RITES Ltd receives LoA from Oil India Ltd
Stock Report
Divis Laboratories Ltd posts Rs. 348 crores consolidated net profit in Q2 FY2024
Posted On : 2023-11-06 15:32:13( TIMEZONE : IST )
Divi's Laboratories Limited has reported Consolidated financial results for the period ended September 30, 2023.
Financial Results (Q2 FY2024) - QoQ Comparison
The company has reported total income of Rs. 1995 crores during the period ended September 30, 2023 as compared to Rs. 1859 crores during the period ended June 30, 2023.
The company has posted net profit / (loss) of Rs. 348 crores for the period ended September 30, 2023 as against net profit / (loss) of Rs. 356 crores for the period ended June 30, 2023.
The company has reported EPS of Rs. 13.11 for the period ended September 30, 2023 as compared to Rs. 13.41 for the period ended June 30, 2023.
| Financials | Q2 FY2024 | Q1 FY2024 | % Change |
| Total Income | ₹ 1995 crs | ₹1859 crs |  7.32% |
| Net Profit | ₹348 crs | ₹356 crs |  -2.25% |
| EPS | ₹13.11 | ₹13.41 | -2.24% |
Financial Results (Q2 FY2024) - YoY Comparison
The company has reported total income of Rs. 1995 crores during the period ended September 30, 2023 as compared to Rs.1935 crores during the period ended September 30, 2022.
The company has posted net profit / (loss) of Rs.348 crores for the period ended September 30, 2023 as against net profit / (loss) of Rs.493 crores for the period ended September 30, 2022.
The company has reported EPS of Rs.13.11 for the period ended September 30, 2023 as compared to Rs.18.60 for the period ended September 30, 2022.
| Financials | Q2 FY2024 | Q2 FY2023 | % Change |
| Total Income | ₹ 1995 crs | ₹1935 crs | 3.10% |
| Net Profit | ₹348 crs | ₹493 crs | -29.41% |
| EPS | ₹13.11 | ₹18.60 | -29.52% |
Financial Results (Half Year Ended FY2024) - YoY Comparison
The company has reported total income of Rs.3854 crores during the 6 Months period ended September 30, 2023 as compared to Rs.4278 crores during the 6 Months period ended September 30, 2022.
The company has posted net profit / (loss) of Rs.704 crores for the 6 Months period ended September 30, 2023 as against net profit / (loss) of Rs.1196 crores for the 6 Months period ended September 30, 2022.
The company has reported EPS of Rs.26.52 for the 6 Months period ended September 30, 2023 as compared to Rs.45.04 for the 6 Months period ended September 30, 2022.
| Financials | Half Year Ended FY2024 | Half Year Ended FY2023 | % Change |
| Total Income | ₹3854 crs | ₹4278 crs | -9.91% |
| Net Profit | ₹704 crs | ₹1196 crs | -41.14% |
| EPS | ₹26.52 | ₹45.04 | -41.12% |
Shares of Divi's Laboratories Limited was last trading in BSE at Rs. 3349.90 as compared to the previous close of Rs. 3344.25. The total number of shares traded during the day was 11773 in over 1832 trades.
The stock hit an intraday high of Rs. 3387.10 and intraday low of 3339.75. The net turnover during the day was Rs. 39601300.00.
